GTR 106028636
Tenders Are Invited For Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Glatiramer Acetate (Atc Code: L03ax13), With The Exception Of The Pre-Filled Pen (Pen) Dosage Form.
ICB — International Competitive Bid
Closes Nov 27, 2027
Western Europe
Tender Information
GTR Reference
106028636
Tendering Authority
Subscribe to view
Tender No
815775-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Glatiramer Acetate (Atc Code: L03ax13), With The Exception Of The Pre-Filled Pen (Pen) Dosage Form.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
27-11-2027
Work Detail
Pharmaceutical Products - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Glatiramer Acetate (Atc Code: L03ax13), With The Exception Of The Pre-Filled Pen (Pen) Dosage Form.. The Aok Niedersachsen Offers The Active Ingredient Glatiramer Acetate (Atc Code: L03ax13), With The Exception Of The Dosage Form Pre-Filled Pen (Pen). The Health Insurance Company Offers Discount Contracts To All Interested Pharmaceutical Companies Without A Selection Decision For The Period Up To The Entry Into Force Of Exclusive Contracts As A Result Of A Formal Award Procedure In Accordance With The Regulations Of Part 4 Of The Gwb. The Contracts Are Concluded As Part Of An “Open-House Model” And Act As A Bridge Between The Start Of Generic Competition (Patent Expiration) And The Award Of Exclusive Contracts. The Contracts Offered Are Not Exclusive; Aok Lower Saxony Wants Contracts With All Market Participants (Pharmaceutical Companies). In The Open-House Model, Uniform Conditions Apply To All Participants. Contract Contents, Conditions And Access Procedures Are Uniform - Individual Negotiations Are Generally Not Carried Out. The Contract Terms Are A Maximum Of Twenty-Four Months; The Earliest Contract Start Date Is February 1, 2026. All Contracts End On January 31, 2028 At The Latest, Regardless Of The Date Of Conclusion Of The Respective Contract. Joining Or Concluding A Contract Can Take Place On The First Of Each Month Within The Twenty-Four Month Period. There Is A Right Of Termination Six Weeks To The End Of The Month. The Aok Lower Saxony. The Health Insurance Fund Reserves The Right To Replace The Non-Exclusive Open-House Discount Agreements With Exclusive Discount Agreements During The Contract Term. When Advertised, Exclusive Discount Contracts Come Into Force, The Open-House Contracts Will Be Terminated In Accordance With The Contractual Regulations, I.E. H. The Open-House Contracts End Automatically. According To Aok Niedersachsens Experience, Exclusive Discount Agreements Usually Come Into Force Six To Eight Months After The Publication Of The Corresponding Tender Notice In The Supplement To The Official Journal Of The European Union. The Future Contractual Partners In The Open-House Model Are Requested To Regularly Consult The Supplement To The Official Journal Of The European Union Regarding These Tender Notices. Interested Pharmaceutical Companies Can Request The Contract Documents And The Contract Conditions At The Contact Address Mentioned Under I.1). Contracts For The Active Ingredient Glatiramer Acetate (Atc Code: L03ax13), With The Exception Of The Dosage Form Pre-Filled Pen (Pen), Will Be Concluded For The First Time With Effect From February 1, 2026. Interested Parties Who Would Like To Become Contractual Partners On This Date Must Submit The Contractual Documents To The Address Specified In The Contractual Documents By December 29, 2025. It Depends On Access To Aok Niedersachsen. Later Contracts Are Possible During The Twenty-Four-Month Maximum Term On The First Of Each Month. From An Organizational Point Of View, A Lead Time Of Usually 35 Calendar Days Is Required
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
88983343-a704-4559-b6c1-b29ddad1b064.html
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.